New Marketplace
Clip
Turning Health Plan Acquisition into Partnership (04:09)

If you’re a big health plan executive and decide to buy some medical groups or hospitals, asks Lawrence Casalino, would this work? What would it take for it to work?

The notion of acquiring physicians or medical groups is troubling, says Sharon Levine. It won’t work unless the behavior inside the organization is truly one of partnership, where there is an environment of commitment, not compliance. “You have to rely on people’s commitment to a mission that involves resource stewardship and a belief that every dollar of somebody else’s money that doesn’t buy a dollar’s worth of health is not only a problem for the patient — it’s a problem for the enterprise,” explains Levine. “And that has to be created through a shared mission and I would say an enacted mission, not just an espoused mission.”

“To make progress, you don’t have to transform into Kaiser or Geisinger,” adds Glenn Steele. “We’re at such an incredibly unacceptable baseline right now that you can do incremental things even with hospital-centric CFOs who are getting paid predominantly fee for service.” Steele notes that about 15–20% of most high-prevalence activities are unindicated; add another 10% in terms of efficiency with unjustified variation, and you have an area in which to create significant value. “In a fee-for-service mode, if you’re starting to get pressure, either from the payer or from ideally the real patient, there’s got to be some value delta where you can start increasing market share,” says Steele. “I don’t know what it is, but if you’re almost the same brand as your competitor, and you’ve got a 5% or a 7% or a 10% value advantage, you ought to start increasing market share.”

From the NEJM Catalyst event Innovation in Health Care Leadership: The New Health Care Marketplace at Northwestern University, June 4, 2015.

More From New Marketplace
Disruption of Innovative Mergers in Health Care Industry - BDO graphic

Innovative Mergers Will Disrupt Health Care

The NEJM Catalyst Insights Council expects outside players to have a major impact on the industry over the next three years.

Mark Miller and Melinda Buntin

MedPAC’s Role in Curtailing Drug Prices

The former Executive Director of the Medicare Payment Advisory Commission lays out three recommendations for curtailing drug prices, as well as upcoming Medicare trends.

Mark Miller and Melinda Buntin

Why Does MedPAC Matter?

The former Executive Director of the Medicare Payment Advisory Commission explains why physicians and health care providers should understand MedPAC’s mission.

Volatility Among Top Health Care Spenders

Consistently High Turnover in the Group of Top Health Care Spenders

Despite the myth of frequent fliers in high-cost health care, most of the top 5% of spenders were not in the top 5% the year before.

Marc Harrison and Leemore Dafny head shots

Fair Pharma? Intermountain’s New Generic Drug Company

“What we aim to do is to create something akin to a public utility that is going to put public good first.”

Changes in household spending 1984-2014 health care spending

My Favorite Slide: Understanding the Growth of Health Care Spending

How have health care costs impacted the everyday life of Americans over the course of a generation?

Proportion of ACOs Achieving Shared Savings under Medicare ACO Programs in the First 3 Years of Payment Contracts

Explaining Sluggish Savings under Accountable Care

ACOs are as diverse as the U.S. health care system. Developing policy approaches that accommodate this diversity will be important for payment and delivery reform to achieve its potential.

NEJM Catalyst single-payer survey results

Why Clinicians Support Single-Payer — and Who Will Win and Lose

Single-payer health care is gaining adherents among physicians and other providers. But as-yet-undetermined details will matter greatly.

What Is Value-Based Healthcare?

Explore the definition, benefits, and examples of value-based healthcare. How does value-based healthcare translate to new delivery models?

Predicting the Future — Big Data, Machine Learning, and Clinical Medicine

By now, it’s almost old news: big data will transform medicine. It’s essential to remember, however, that data by themselves are useless.

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

Topics

Resolving the Payer-Employer Disconnect

Payers need to break out of their insular way of thinking.

Value Based Care

141 Articles

MedPAC’s Role in Curtailing Drug Prices

The former Executive Director of the Medicare Payment Advisory Commission lays out three recommendations for…

Innovative Mergers Will Disrupt Health Care

The NEJM Catalyst Insights Council expects outside players to have a major impact on the…

Insights Council

Have a voice. Join other health care leaders effecting change, shaping tomorrow.

Apply Now